Defining the Molecular Signature of Chemotherapy-Mediated Lung Tumor Phenotype Modulation and Increased Susceptibility to T-Cell Killing
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Defining the Molecular Signature of Chemotherapy-Mediated Lung Tumor Phenotype Modulation and Increased Susceptibility to T-Cell Killing
Authors
Keywords
-
Journal
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
Volume 27, Issue 1, Pages 23-35
Publisher
Mary Ann Liebert Inc
Online
2012-02-09
DOI
10.1089/cbr.2012.1203
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin 1α Sustains the Expression of Inflammatory Factors in Human Pancreatic Cancer Microenvironment by Targeting Cancer-Associated Fibroblasts
- (2015) Vegard Tjomsland et al. NEOPLASIA
- Varied Pathways of Stage IA Lung Adenocarcinomas Discovered by Integrated Gene Expression Analysis
- (2012) Chengwen Chen et al. International Journal of Biological Sciences
- Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses
- (2011) Sofia R. Gameiro et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
- (2011) Dalil Hannani et al. CANCER JOURNAL
- Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2011) Yue Wang et al. CYTOKINE
- RNA Interference Targeting Slug Increases Cholangiocarcinoma Cell Sensitivity to Cisplatin via Upregulating PUMA
- (2011) Kejun Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT
- (2011) Najoua Lalaoui et al. PLoS One
- Therapeutic Targeting of CD95 and the TRAIL Death Receptors
- (2011) Jeannette Gerspach et al. Recent Patents on Anti-Cancer Drug Discovery
- Spectroscopic studies of dactinomycin and vinorelbine binding to deoxyribonucleic acid and chromatin
- (2011) Azra Rabbani-Chadegani et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells
- (2011) Ramon Kaneno et al. CELLULAR ONCOLOGY
- Desirable cell death during anticancer chemotherapy
- (2010) Clara Locher et al. Annals of the New York Academy of Sciences
- TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
- (2010) Shumin Wang et al. BMC CANCER
- PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis
- (2010) Jerry E. Chipuk et al. CELL CYCLE
- Tumor Regression and Growth Rates Determined in Five Intramural NCI Prostate Cancer Trials: The Growth Rate Constant as an Indicator of Therapeutic Efficacy
- (2010) W. D. Stein et al. CLINICAL CANCER RESEARCH
- The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells
- (2010) Romaine I. Fernando et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
- (2010) Rupal Ramakrishnan et al. JOURNAL OF CLINICAL INVESTIGATION
- BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells
- (2010) Jing Da Xu et al. JOURNAL OF PATHOLOGY
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Role of the Unfolded Protein Response Regulator GRP78/BiP in Development, Cancer, and Neurological Disorders
- (2009) Miao Wang et al. ANTIOXIDANTS & REDOX SIGNALING
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- Snail Promotes CXCR2 Ligand-Dependent Tumor Progression in Non-Small Cell Lung Carcinoma
- (2009) J. Yanagawa et al. CLINICAL CANCER RESEARCH
- Transforming growth factor beta (TGF-β) and inflammation in cancer
- (2009) Brian Bierie et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The effect of vinca alkaloid anticancer drug, vinorelbine, on chromatin and histone proteins in solution
- (2009) Azra Rabbani-Chadegani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism
- (2009) G. V. Shurin et al. JOURNAL OF IMMUNOLOGY
- Secreted Interleukin-1 Induces a Metastatic Phenotype in Pancreatic Cancer by Sustaining a Constitutive Activation of Nuclear Factor- B
- (2009) D. Melisi et al. MOLECULAR CANCER RESEARCH
- Vaccines for the Treatment of Non-Small Cell Lung Cancer: A Renewed Anticancer Strategy
- (2009) C. Gridelli et al. ONCOLOGIST
- Cisplatin up-regulates ICAM-1 expression in endothelial cell via a NF-κB dependent pathway
- (2008) Minghua Yu et al. CANCER SCIENCE
- Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement
- (2008) C. T. Garnett et al. CLINICAL CANCER RESEARCH
- Combined effects of 5-Fluorouracil, Folinic acid and Oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy
- (2008) Salvatore P Prete et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started